BYD-AUTO
21.11.2023 02:00:47 CET | Business Wire | Press release
BYD, the world’s leading manufacturer of new energy vehicles, showcased its full lineup of vehicles at the 21st Guangzhou International Automobile Exhibition from November 17th to 26th. BYD featured the global debut of the e⁴ concept car, the release of the Supercar Platform, and the unveiling of the new pure electric SUV—the BYD Sea Lion 07 EV*.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20231120172380/en/
New concept car of Yangwang (Photo: Business Wire)
Yangwang Unveiled a New e⁴ Concept Car and Supercar Platform
BYD's premium sub-brand Yangwang dazzled with the debut of its latest e⁴ concept car, supercar platform, and brought U8 and U9 to the auto show. The e⁴ concept car by Yangwang lacked traditional steering gear and braking mechanisms. It employed a three-in-one technology for driving, braking, and steering, eliminating the need for conventional mechanical systems. Earlier this year, Yangwang introduced the exclusive Yangwang Architecture for high-end new energy vehicles. The Supercar Platform under this architecture made its official debut, marking Yangwang's transition from the wilderness to the racetrack with cutting-edge technology. At the exhibition, the interior of the Yangwang U9 was unveiled for the first time, showcasing a cockpit that exuded both technological sophistication and sportiness.
Sea Lion 07 EV*: A New Member of the BYD Ocean Series
BYD Ocean Series unveiled its first mid-sized pure electric SUV, the Sea Lion 07 EV*, at the exhibition. Embracing the 'Ocean Aesthetics' design philosophy, it utilized rear-wheel/four-wheel drive architecture, equipped with CTB technology and iTAC intelligent torque control technology. Additionally, it featured front double-wishbone and rear five-link independent suspension, along with the BYD DiSus Intelligent Body Control System. Currently, the Ocean Series boasts several popular models such as the Dolphin, Seal, establishing a robust Ocean Series IP. In the future, the Ocean Series would consolidate SUV models under the intellectual property of Sea Lion* and sedan models under the intellectual property of Seal.
Denza D9 PREMIER (inaugural edition with four seats) Showcased its Intelligent Configurations
Denza, another high-end sub-brand under BYD's diversified brand matrix, presented the D9 PREMIER (inaugural edition with four seats) along with several cutting-edge technologies. The exterior of D9 PREMIER (inaugural edition with four seats) adopted a galaxy dual-tone body, and the interior featured the application of intangible cultural heritage gilding techniques. The cabin was equipped with 22 DEVIALET audio speakers and a premier intelligent customized cockpit, including an 8-inch armrest screen.
In December, high-speed NOA (Navigate on Autopilot) will be rolled out to consumers, followed by the gradual release of urban NOA in Q1 of next year. High-speed NOA-enabled vehicles will be delivered to consumers in December. Additionally, features such as Sentry Mode, Light Map Mode, and Commute Mode will progressively roll out next year.
FANGCHENGBAO and the Stunning BAO 5
BYD's professional personalized sub-brand FANGCHENGBAO also brought its BAO 5 to the exhibition. The BAO 5, which was just launched last week, positioned itself as a "Super Hybrid Hardcore SUV" starting at 289,800 RMB and was equipped with BYD's core technologies such as DMO and DiSus-P. BAO 5 used the ultra-safe blade battery, which adopted a 5-layer protection structure and was shielded by a ring-type double protection system.
BYD had a total of 4 booths at the 21st Guangzhou International Automobile Exhibition, which continued until November 26th. Various of BYD’s hardcore technologies, including the Dual Mode Off-road (DMO) Super Hybrid Platform, BYD DiSus Intelligent Body Control System, and e⁴ Platform also made appearances by some display platforms at this exhibition. BYD demonstrated its pioneer technology and leading advancements, contributing to helping cool the earth by 1℃.
(The product name with the "*" mark in this press release is a translation from the Chinese product name and is currently only applicable for the expressions of models launched in China.)
About BYD
BYD is a multinational high-tech company devoted to leveraging technological innovations for a better life. Founded in 1995 as a rechargeable battery maker, BYD now boasts a diverse business scope covering automobiles, rail transit, new energy, and electronics, with over 30 industrial parks in China, the United States, Canada, Japan, Brazil, Hungary, and India. From energy generation and storage to its applications, BYD is dedicated to providing zero-emission energy solutions that reduce global reliance on fossil fuels. Its new energy vehicle footprint now covers 6 continents, over 70 countries and regions, and more than 400 cities. Listed in both Hong Kong and Shenzhen Stock Exchanges, the company is known to be a Fortune Global 500 enterprise that furnishes innovations in pursuit of a greener world.
For more information, please visit www.bydglobal.com.
About BYD Auto
Founded in 2003, BYD Auto is the automotive subsidiary of BYD, a multinational high-tech company devoted to leveraging technological innovations for a better life. Aiming to accelerate the green transition of the global transportation sector, BYD Auto focuses on developing pure electric and plug-in hybrid vehicles. The company has mastered the core technologies of the entire industrial chain of new energy vehicles, such as batteries, electric motors, and electronic controllers. It has witnessed in recent years significant technological advancements, including the Blade Battery, DM-i Super Hybrid Technology, e Platform 3.0, CTB Technology, e⁴ Platform, BYD DiSus Intelligent Body Control System, and DMO super hybrid system. The company is the world's first carmaker to stop the production of fossil-fueled vehicles on the EV shift and has remained top of new energy passenger vehicle sales in China for 10 years in a row.
For more information, please visit www.byd.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20231120172380/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
KATE Launches "KABUKE: Break Convention" Kabuki-Inspired International Campaign17.7.2026 09:00:00 CEST | Press release
Where “NO MORE RULES.” intersects with the Kabuku spirit. Inspired by Japanese aesthetics, KATE shares the value of shadow enhancing makeup and self‑expression with the world. Global cosmetics brand KATE launched “KABUKE: Break Convention,” a new international campaign drawing on elements of Kabuki, the traditional Japanese performing art. The campaign debuted on Wednesday, July 8, 2026. In this campaign, KATE’s shadow enhancing makeup—rooted in Japanese aesthetics—was paired with the Kabuki spirit inherited from traditional Kabuki theater to communicate the value of individuality and self‑expression through makeup on a global scale. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260708829427/en/ KATE international campaign “KABUKE: Break Convention” key visual. Dedicated website: https://www.kate-global.net/my/special/kate_kabuki/ Since its founding, KATE has championed the slogan “NO MORE RULES.,” offering makeup that defi
Meiji Seika Pharma: Results from the Global Phase III Trial (Integral-2) of Nacubactam, a Novel β-Lactamase Inhibitor, Highlighted in The Lancet Microbe’s Coverage of ESCMID Global Congress 202617.7.2026 03:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, President and Representative Director: Toshiaki Nagasato) today announced that results from the global Phase III trial (Integral-2) of nacubactam (Development Code: OP0595), a novel β-lactamase inhibitor, were highlighted in The Lancet Microbe’s coverage of ESCMID Global Congress 2026 (held in Munich, Germany). As highlighted in The Lancet Microbe’s coverage, the key findings presented by Meiji Seika Pharma at ESCMID Global Congress 2026 are as follows: The Integral-2 study (jRCT2031230076) is a global Phase III clinical trial that enrolled patients with complicated urinary tract infections, acute uncomplicated pyelonephritis, hospital-acquired bacterial pneumonia, ventilator-associated bacterial pneumonia, or complicated intra-abdominal infections caused by carbapenem-resistant Gram-negative bacteria (excluding Acinetobacter species). The study has achieved the prespecified study objectives. For the primary endpoint of overall treatme
Yoshihiro Shimamura Joins the Marché du Film’s “Investors Circle 2026” as an Invited Investor, Backing a New Feature Film17.7.2026 03:00:00 CEST | Press release
Shimamura Yoshihiro Film Production Co., Ltd. (Head office: Osaka, Japan; Representative Director: Yoshihiro Shimamura), a company active in film production and investment, today announced that Representative Director Yoshihiro Shimamura has decided to invest in an international feature film after being invited to the “Investors Circle 2026” — a distinction that reflects his standing as one of the field’s most highly regarded producers and investors. Hosted by the Marché du Film, the business arm of the Festival de Cannes and one of the world’s largest film markets, the Investors Circle is an invitation-only summit that connects a select group of private investors with high-end feature films during early-stage financing. Held in Cannes, France, May 16-17, 2026, it brings internationally acclaimed directors and producers together with investors around a curated slate of projects in development. During the summit, Shimamura attended private pitching sessions and, after individual meeting
Takeda’s Zasocitinib Demonstrates Consistent, High Rates of Skin Clearance Across the Body, Including Hard-to-Treat and High-Impact Sites, in Phase 3 Psoriasis Studies17.7.2026 00:00:00 CEST | Press release
On average, about 75% of patients with scalp psoriasis treated with zasocitinib achieved clear or almost clear skin at week 16 Approximately 70% of patients with palmoplantar disease treated with zasocitinib achieved clear or almost clear skin at week 16 Zasocitinib demonstrated statistically significant improvements in Nail Psoriasis Severity Index (NAPSI) versus placebo Results reinforce the potential of zasocitinib to deliver rapid and durable skin clearance, including in the hardest-to-treat areas, in a convenient once-daily pill Takeda (TSE:4502/NYSE:TAK) announced new data from the two pivotal Phase 3 studies of zasocitinib (TAK-279), a next-generation, highly selective and potent oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented at the 2026 American Academy of Dermatology (AAD) Innovation Academy, these secondary endpoint data show that zasocitinib demonstrated consistent and high rates of skin clearance across hard-to-
Merz Completes Inaugural €450 Million Schuldschein Loan Issuance16.7.2026 23:36:00 CEST | Press release
Debut transaction more than three times oversubscribed The Merz Group has successfully completed its first-ever Schuldschein loan issuance, placing a total volume of €450 million in the debt capital market – a multiple of three relating to the launch volume. The debut transaction was significantly oversubscribed and attracted strong interest from all investor groups. The proceeds were settled and paid out today. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260716926041/en/ Dr. Almuth Steinkühler, Chief Financial Officer Merz Group The transaction comprises both fixed- and floating-rate tranches with maturities of three, five, seven, and ten years. Around 50 German and international investors participated, representing a broad range of institutions, including private banks, German federal state-owned banks, public savings banks, cooperative banks, pension funds and occupational pension institutions. With the successful plac
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom